Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases

Lisa KobrynskiDepartment of Pediatrics, Emory University, Atlanta, GA, USAAbstract: Since the 1950s, replacement of immunoglobulin G using human immunoglobulin has been the standard treatment for primary immunodeficiency diseases with defects in antibody production. These patients suffer from recurr...

Full description

Saved in:
Bibliographic Details
Main Author: Kobrynski L
Format: article
Language:EN
Published: Dove Medical Press 2012
Subjects:
Online Access:https://doaj.org/article/5352b791509b4c489e7611f4de1324f9
Tags: Add Tag
No Tags, Be the first to tag this record!